COM:APELLIS
Apellis Pharmaceuticals, Inc.
- Stock
Last Close
25.04
10/03 20:00
Market Cap
3.16B
Beta: -
Volume Today
1.36M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.79M - | -46.52M 331.16% | -27.12M 41.69% | -51.01M 88.04% | -127.50M 149.97% | -304.71M 138.98% | -344.87M 13.18% | -746.35M 116.41% | -652.17M 12.62% | -528.63M 18.94% | |
depreciation and amortization | 6.59K - | 11.94K - | 239.68K - | 637K 165.77% | 1.49M 134.22% | 1.49M 0.34% | 1.70M 14.59% | ||||
deferred income tax | 153.69K - | 16.34M - | 103.03M 530.52% | 198.26M 92.44% | -368.55M - | ||||||
stock based compensation | 659.15K - | 545.70K 17.21% | 1.08M 97.73% | 5.42M 402.20% | 7.73M 42.71% | 21.14M 173.42% | 45.38M 114.60% | 70.67M 55.74% | 91.08M 28.89% | 105.94M 16.31% | |
change in working capital | 175.01K - | 628.31K 259.00% | 42.57K 93.22% | -1.19M 2,888.00% | -12.04M 914.44% | 53.15M 541.43% | 19.59M 63.15% | -93.52M 577.49% | -15.70M 83.21% | -200.17M 1,175.12% | |
accounts receivables | -10.10M - | 2.38M 123.51% | -198.72M 8,466.95% | ||||||||
inventory | -16.32M - | -69.40M 325.30% | -60.65M 12.61% | ||||||||
accounts payables | 397.66K - | 1.73M 334.01% | 69.78K 95.96% | 932.30K 1,236.07% | 6.59M 606.58% | -1.64M 124.91% | -54K 96.71% | 10.49M 19,520.37% | 18.69M 78.21% | 170K 99.09% | |
other working capital | -222.65K - | -1.10M 392.98% | -27.21K 97.52% | -2.12M 7,688.80% | -18.63M 779.00% | 54.79M 394.13% | 19.64M 64.15% | -77.59M 495.06% | 32.63M 142.06% | 59.02M 80.86% | |
other non cash items | 804 - | 26.49M 3,294,178.61% | 13.56K - | 568.33K 4,090.26% | 2.70M 374.67% | 15.76M 484.13% | 6.33M 59.85% | 61.55M 872.86% | 394.96M 541.66% | ||
net cash provided by operating activities | -9.95M - | -18.86M 89.57% | -26.00M 37.90% | -46.60M 79.19% | -131.24M 181.66% | -211.14M 60.88% | -160.49M 23.99% | -563.13M 250.88% | -513.75M 8.77% | -594.74M 15.76% | |
investments in property plant and equipment | -19.95K - | -1.69M - | -5.42M 220.20% | -1.10M 79.66% | -1.52M 38.17% | -773K 49.28% | |||||
acquisitions net | 311.57M - | -248.72M 179.83% | -61.42M 75.31% | 99K 100.16% | |||||||
purchases of investments | -879.07M - | -171.28M 80.52% | -331.86M 93.75% | ||||||||
sales maturities of investments | 567.50M - | 420M 25.99% | 393.28M 6.36% | ||||||||
other investing activites | -311.57M - | 248.72M 179.83% | 61.42M 75.31% | ||||||||
net cash used for investing activites | -19.95K - | -1.69M - | -316.99M 18,619.95% | 247.62M 178.12% | 59.89M 75.81% | -674K 101.13% | |||||
debt repayment | -28.70M - | -322.87M 1,024.95% | |||||||||
common stock issued | 1.72K - | 150.06M - | 131.19M 12.57% | 109.58M 16.47% | 381.42M 248.07% | 380.36M 0.28% | 380.12M 0.06% | 461.04M 21.29% | |||
common stock repurchased | 1.57M - | 2.97M 88.57% | 4.24M 42.69% | ||||||||
dividends paid | -322.87M - | ||||||||||
other financing activites | 18.83M - | 41.23M 118.97% | 14.86M 63.96% | 47.31M 218.32% | 709.33K 98.50% | 307.66M 43,273.56% | 954.93M 210.38% | 8.90M 99.07% | -18.70M 310.03% | -66.54M 255.85% | |
net cash used provided by financing activities | 18.83M - | 41.24M 118.98% | 14.86M 63.96% | 197.38M 1,227.96% | 131.90M 33.17% | 388.54M 194.57% | 692.18M 78.15% | 392.24M 43.33% | 365.66M 6.78% | 394.50M 7.89% | |
effect of forex changes on cash | -38.43K - | 4.70K 112.24% | 359K 7,535.05% | -2.02M 661.56% | -488K 75.79% | 135K 127.66% | |||||
net change in cash | 8.86M - | 22.38M 152.47% | -11.14M 149.78% | 150.78M 1,453.49% | 624.14K 99.59% | 175.72M 28,053.66% | 215.06M 22.39% | 74.71M 65.26% | -88.68M 218.70% | -200.78M 126.40% | |
cash at beginning of period | 4.76M - | 13.62M 186.30% | 36.00M 164.29% | 24.86M 30.94% | 175.64M 606.43% | 176.27M 0.36% | 351.99M 99.69% | 567.04M 61.10% | 641.75M 13.18% | 553.07M 13.82% | |
cash at end of period | 13.62M - | 36.00M 164.29% | 24.86M 30.94% | 175.64M 606.43% | 176.27M 0.36% | 351.99M 99.69% | 567.04M 61.10% | 641.75M 13.18% | 553.07M 13.82% | 352.30M 36.30% | |
operating cash flow | -9.95M - | -18.86M 89.57% | -26.00M 37.90% | -46.60M 79.19% | -131.24M 181.66% | -211.14M 60.88% | -160.49M 23.99% | -563.13M 250.88% | -513.75M 8.77% | -594.74M 15.76% | |
capital expenditure | -19.95K - | -1.69M - | -5.42M 220.20% | -1.10M 79.66% | -1.52M 38.17% | -773K 49.28% | |||||
free cash flow | -9.97M - | -18.86M 89.19% | -26.00M 37.90% | -46.60M 79.19% | -131.24M 181.66% | -212.83M 62.17% | -165.91M 22.05% | -564.23M 240.08% | -515.27M 8.68% | -595.51M 15.57% |
All numbers in USD (except ratios and percentages)